Zeguang Han

Chair Professor & Distinguished Professor of Yangtze River Scholar. Director of Center for Systems Biomedicine, Shanghai Jiao Tong University & Key Laboratory of Systems Biomedicine (Ministry of Education)

 

Tel: 021-34206124
Fax: 021-34206124
Email: hanzg@sjtu.edu.cn
Homepage: http://hanlab.sjtu.edu.cn

 

 

Talent Awards
1. We characterized the genome-wide DNA mutational, copy number aberration, transcriptomic, and DNA methylation patterns of human liver cancer, and identified some tumor-associated genes and potential drug targets including ARID1A, IRTKS, DLK1,LZP et al( Gut, 2018; Hepatology, 2013,2014,2020; Oncogene 2022;Liver International,2022;JHO, 2021; CDD, 2021; Cancer lett. 2022; PLoS Genet. 2021; EBioMedicine. 2019; Nat Genet 2012). Won the first prize of natural science of Ministry of Education.
2. Systems biological studies on molecular basis for parasitism and pathogenicity of Schistosoma japonicum (Nature, 2009; Nat Genet 2003; PLoS Pathogens, 2006, MCP, 2009; Annu Rev Genomics Hum Genet, 2009). Won the second prize of National Natural Science Award, the first prize of Natural Science of the Ministry of Education, and the first prize of Shanghai Natural Science Award.

 

1. Focus on the identification of key genetic and epigenetic abnormalities involved in liver cancer and other tumors as well as clarification of the molecular and cellular mechanisms of these aberrations based on systems biology approaches and animal models;
2. Based on tumors (liver cancer) molecular markers and potential drug targets, development of the potential therapeutic approaches against cancers.
3. The establishing of new single cell technologies and novel bioinformatics tools for genome, epigenome and transcriptome for charactering the features of cancer cells and microenvironmental cells。

1. Xianbin Su,Shihao Bai, Gangcai Xie,Yi Shi,Linan Zhao,Guoliang Yang,Futong Tian,Kun-Yan He,Lan Wang,Xiaolin Li,Qi Long, Ze-Guang Han. Accurate tumor clonal structures require single-cell analysis. Annals NY Academy of Science. 08 September 2022 https://doi.org/10.1111/nyas.14897
2. LanWang, Chuan-HuaiDeng, QingLuo, Xian-BinSu, Xue-YingShang, Shu-JinSong, ShengCheng, Yu-LanQu, XinZou, YiShi, QianWang, Shi-ChunDu, Ze-GuangHan. Inhibition of Arid1a increases stem/progenitor cell-like properties of liver cancer. Cancer Letters. Volume 546, 10 October 2022, 215869
https://doi.org/10.1016/j.canlet.2022.215869
3. Yangyang Zhai,Kunyan He,Liyu Huang,Xuyang Shang,Guangxing Wang,Guandou Yuan,Ze-Guang Han. DLK1-directed chimeric antigen receptor T-cell therapy for hepatocellular carcinoma. Liver International. 24 August 2022 https://doi.org/10.1111/liv.15411
4. Dan-Dan He, Xue-Ying Shang, Na Wang, Guang-Xing Wang, Kun-Yan He, Lan Wang, Ze-Guang Han. BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage. Oncogene. 2022 Mar;41(10):1397-1409. doi: 10.1038/s41388-022-02176-2. Epub 2022 Jan 11.
5. Lan Wang, Shi-Hao Bai, Shu-Jin Song, Zhao-Ning Lu, Jian Huang, Ze-Guang Han. Exposure to aristolochic acid I is associated with poor prognosis of liver cancer patients. Toxicol Res (Camb) . 2022 Jan 29;11(1):255-260. doi: 10.1093/toxres/tfac002. eCollection 2022 Feb.
6. Xianbin Su, Linan Zhao, Yi Shi, Rui Zhang, Qi Long, Shihao Bai, Qing Luo, Yingxin Lin, Xin Zou, Shila Ghazanfar, Kun Tao, Guoliang Yang, Lan Wang, Kun-Yan He, Xiaofang Cui, Jian He, Jiao-Xiang Wu, Bo Han, Bin Yan, Biao Deng, Na Wang, Xiaolin Li, Pengyi Yang, Shangwei Hou, Jielin Sun, Jean Y H Yang, Jinhong Chen, Ze-Guang Han. Clonal evolution in liver cancer at single-cell and single-variant resolution. J Hematol Oncol. 2021 Feb 2;14(1):22. doi: 10.1186/s13045-021-01036-y.
7. Jiao-Xiang Wu, Kun-Yan He, Zhuang-Zhuang Zhang, Yu-Lan Qu, Xian-Bin Su, Yi Shi, Na Wang, Lan Wang, Ze-Guang Han. LZP is required for hepatic triacylglycerol transportation through maintaining apolipoprotein B stability. PLoS Genet. 2021 Feb 16;17(2):e1009357. doi: 10.1371/journal.pgen.1009357. eCollection 2021 Feb.
8. Xue-Ying Shang, Yi Shi, Dan-Dan He, Lan Wang, Qing Luo, Chuan-Huai Deng, Yu-Lan Qu, Na Wang, Ze-Guang Han. ARID1A deficiency weakens BRG1-RAD21 interaction that jeopardizes chromatin compactness and drives liver cancer cell metastasis. Cell Death Dis. 2021 Oct 23;12(11):990. doi: 10.1038/s41419-021-04291-6.
9. Kunyan He,Guang-Xing Wang,Li-Nan Zhao,Xiao-Fang Cui, Xian-Bin Su, Yi Shi, Tian-Pei Xie, Shang-Wei Hou, Ze-Guang Han. Cinobufagin Is a Selective Anti-Cancer Agent against Tumors with EGFR Amplification and PTEN Deletion. Front. Pharmacol., 2021 https://doi.org/10.3389/fphar.2021.775602
10. Shi Y, Zhang M, Meng L, Su X, Shang X, Guo Z, Li Q, Lin M, Zou X, Luo Q, Yu Y, Wu Y, Da L, Cai TW, He G, Han ZG. A novel neoantigen discovery approach based on chromatin high order conformation. BMC Med Genomics. 2020 Aug 27;13(Suppl 6):62.
11. Zhang F, Yan P, Yu H, Le H, Li Z, Chen J, Liang X, Wang S, Wei W, Liu L, Zhang Y, Ji X, Xie A, Chen W, Han Z, Pu WT, Chen S, Chen Y, Sun K, Ge B, Zhang B. LARP7 Is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis. Cell Rep. 2020 Aug 18;32(7):108058
12. Jiang HW, Zhang HN, Meng QF, Xie J, Li Y, Chen H, Zheng YX, Wang XN, Qi H, Zhang J, Wang PH, Han ZG, Tao SC. SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70. Cell Mol Immunol. 2020 Sep;17(9):998-1000.
13. Ghazanfar S, Lin Y, Su X, Lin DM, Patrick E, Han ZG, Marioni JC, Yang JYH. Investigating higher-order interactions in single-cell data with scHOT. Nat Methods. 2020 Aug;17(8):799-806.
14. Shi Y, Guo Z, Su X, Meng L, Zhang M, Sun J, Wu C, Zheng M, Shang X, Zou X, Cheng W, Yu Y, Cai Y, Zhang C, Cai W, Da L, He G, Han ZG. DeepAntigen: A Novel Method for Neoantigen Prioritization via 3D Genome and Deep Sparse Learning.  Bioinformatics. 2020 Jun 27:btaa596.
15. Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020 2020 Apr;14(2):185-192 (热点文章,高被引文章)
16. Su X, Long Q, Bo J, Shi Y, Zhao LN, Lin Y, Luo Q, Ghazanfar S, Zhang C, Liu Q, Wang L, He K, He J, Cui X, Yang JYH, Han ZG, Yang G, Sha JJ. Mutational and transcriptomic landscapes of a rare human prostate basal cell carcinoma. Prostate. 2020 May;80(6):508-517
17. Lu ZN, Luo Q, Zhao LN, Shi Y, Wang N, Wang L, Han ZG. The mutational features of aristolochic acid-induced mouse and human liver cancers. Hepatology. 2020 Mar;71(3):929-942.
18. Qu YL, Deng CH, Luo Q, Shang XY, Wu JX, Shi Y, Wang L, Han ZG. Arid1a regulates insulin sensitivity and lipid metabolism. EBioMedicine. 2019 Apr; 42: 481-493. doi: 10.1016/j.ebiom.2019.03.021. Epub 2019 Mar 14.

Copyright © 2016 开云官方在线登陆入口-开云online(中国) 版权所有
Shared by

Address:800 Dongchuan Road, Shangha
Fax:200240
Tel:021-34206059